Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
Rhea-AI Summary
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ear, nose and throat (ENT) and allergy treatments, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management team will deliver a company overview and business update on December 5, 2024, at 1:30 p.m. ET. The presentation will be accessible via webcast on the Investors page of the Optinose website, with replay availability for 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction – OPTN
In the trading session that priced this news, OPTN gained 7.58%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024 at 1:30 p.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
